Palforzia Archives -

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s

NICE backs Aimmune’s peanut allergy drug Palforzia for children

https://pharmaphorum.com/news/nice-backs-aimmunes-peanut-allergy-drug-palforzia-for-children/

DBV Technologies’ long and tortuous path to an FDA verdict on its Viaskin Peanut allergy shot has led

DBV craters on FDA’s peanut allergy immunotherapy rejection

https://pharmaphorum.com/news/dbv-craters-on-fdas-peanut-allergy-immunotherapy-rejection/

The FDA has approved the first ever peanut allergy treatment, backing Aimmune’s Palforzia to reduce reactions in children.

FDA approves first ever peanut allergy therapy from Aimmune

https://pharmaphorum.com/news/fda-approves-first-ever-peanut-allergy-therapy-from-aimmune/

Palforzia